Pages that link to "Q40644970"
Jump to navigation
Jump to search
The following pages link to Gene transfer of Ig-fusion proteins into B cells prevents and treats autoimmune diseases (Q40644970):
Displaying 50 items.
- Transplantation Tolerance Induction: Cell Therapies and Their Mechanisms (Q26751022) (← links)
- Cell therapy to induce allograft tolerance: time to switch to plan B? (Q27013040) (← links)
- Novel GLP-1 Fusion Chimera as Potent Long Acting GLP-1 Receptor Agonist (Q28475510) (← links)
- Immune regulation by B cells and antibodies a view towards the clinic. (Q33381036) (← links)
- Killer B lymphocytes: the evidence and the potential (Q33943014) (← links)
- B-cell delivered gene therapy for tolerance induction: role of autoantigen-specific B cells (Q34079588) (← links)
- Regulatory T cell epitopes (Tregitopes) in IgG induce tolerance in vivo and lack immunogenicity per se. (Q34348211) (← links)
- Inhibitors - cellular aspects and novel approaches for tolerance (Q34380850) (← links)
- Anergy in memory CD4+ T cells is induced by B cells (Q34784998) (← links)
- Development of Gene Transfer for Induction of Antigen-specific Tolerance (Q34794525) (← links)
- B-Cell Gene Therapy for Tolerance Induction: Host but Not Donor B-Cell Derived IL-10 is Necessary for Tolerance (Q35116488) (← links)
- Gene therapy in autoimmune, demyelinating disease of the central nervous system (Q35122159) (← links)
- Vectors for the treatment of autoimmune disease. (Q35122178) (← links)
- B cells "transduced" with TAT-fusion proteins can induce tolerance and protect mice from diabetes and EAE (Q35172788) (← links)
- Gene therapy in systemic lupus erythematosus (Q35824504) (← links)
- Gene therapy for autoimmune diseases: quo vadis? (Q35906093) (← links)
- Toll-like receptor 4-activated B cells out-compete Toll-like receptor 9-activated B cells to establish peripheral immunological tolerance (Q35974011) (← links)
- Cytokine-neuroantigen fusion proteins as a new class of tolerogenic, therapeutic vaccines for treatment of inflammatory demyelinating disease in rodent models of multiple sclerosis (Q36174813) (← links)
- Reprogrammed quiescent B cells provide an effective cellular therapy against chronic experimental autoimmune encephalomyelitis (Q36201277) (← links)
- Lentiviral vectors displaying modified measles virus gp overcome pre-existing immunity in in vivo-like transduction of human T and B cells. (Q36220659) (← links)
- Tolerance to MHC class II disparate allografts through genetic modification of bone marrow (Q36836700) (← links)
- B cells induce tolerance by presenting endogenous peptide-IgG on MHC class II molecules via an IFN-gamma-inducible lysosomal thiol reductase-dependent pathway (Q36983280) (← links)
- Antigen-specific tolerogenic and immunomodulatory strategies for the treatment of autoimmune arthritis (Q37051562) (← links)
- Activated B cells in autoimmune diseases: the case for a regulatory role (Q37335863) (← links)
- The regulated long-term delivery of therapeutic proteins by using antigen-specific B lymphocytes. (Q37621601) (← links)
- Suppressive functions of activated B cells in autoimmune diseases reveal the dual roles of Toll-like receptors in immunity. (Q37700798) (← links)
- Advances in the field of lentivector-based transduction of T and B lymphocytes for gene therapy (Q37782256) (← links)
- B cells as effectors and regulators of autoimmunity (Q37995319) (← links)
- Natural autoantibodies and associated B cells in immunity and autoimmunity (Q38062945) (← links)
- Type 1 diabetes therapy beyond T cell targeting: monocytes, B cells, and innate lymphocytes (Q38117282) (← links)
- In vivo reprogramming of immune cells: Technologies for induction of antigen-specific tolerance. (Q39245827) (← links)
- High Efficiency Ex Vivo Gene Transfer to Primary Murine B Cells Using Plasmid or Viral Vectors (Q39553529) (← links)
- Targeting MOG expression to dendritic cells delays onset of experimental autoimmune disease (Q39649689) (← links)
- Lentiviral gene transfer of CTLA4 generates B cells with reduced costimulatory properties (Q39790381) (← links)
- Gene therapy for immunological tolerance: using 'transgenic' B cells to treat inhibitor formation (Q39865349) (← links)
- Immune Modulatory Cell Therapy for Hemophilia B Based on CD20-Targeted Lentiviral Gene Transfer to Primary B Cells. (Q40211579) (← links)
- Gene therapy of diabetes using a novel GLP-1/IgG1-Fc fusion construct normalizes glucose levels in db/db mice (Q40237694) (← links)
- Cell-based gene therapy experiments in murine experimental autoimmune encephalomyelitis (Q40445781) (← links)
- Induction of tolerance to factor VIII inhibitors by gene therapy with immunodominant A2 and C2 domains presented by B cells as Ig fusion proteins (Q40446327) (← links)
- Baboon envelope pseudotyped lentiviral vectors efficiently transduce human B cells and allow active factor IX B cell secretion in vivo in NOD/SCIDγc-/- mice. (Q40560385) (← links)
- B-cell-delivered gene therapy induces functional T regulatory cells and leads to a loss of antigen-specific effector cells (Q42502298) (← links)
- CD8+ regulatory T cells are responsible for GAD-IgG gene-transferred tolerance induction in NOD mice (Q44347477) (← links)
- Stem cells engineered to express self-antigen to treat autoimmunity (Q45861637) (← links)
- Transplantation of bone marrow genetically engineered to express proinsulin II protects against autoimmune insulitis in NOD mice (Q45862670) (← links)
- Transduced B cells: B is for ‘beneficial’! (Q45870388) (← links)
- Non-myeloablative transplantation of bone marrow expressing self-antigen establishes peripheral tolerance and completely prevents autoimmunity in mice (Q45874884) (← links)
- From IgG Fusion Proteins to Engineered-Specific Human Regulatory T Cells: A Life of Tolerance (Q45875104) (← links)
- Retroviral delivery of GAD-IgG fusion construct induces tolerance and modulates diabetes: a role for CD4+ regulatory T cells and TGF-beta? (Q45877596) (← links)
- Antigen-specific humoral tolerance or immune augmentation induced by intramuscular delivery of adeno-associated viruses encoding CTLA4-Ig-antigen fusion molecules (Q45881605) (← links)
- Bone marrow transplantation combined with gene therapy to induce antigen-specific tolerance and ameliorate EAE. (Q45887585) (← links)